NEOG vs TRIB
Neogen Corp. and Trinity Biotech PLC, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | NEOG | TRIB |
|---|---|---|
| Revenue | $870.4M | $61.6M |
| Net income | $-7.9M | $-31.8M |
| Gross margin | 46.9% | 34.8% |
| Net margin | −0.9% | −50.7% |
| Return on equity | −0.4% | · |
| Diluted EPS | −$0.04 | · |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $31.9M | $-4.6M |
| Equity | $2.1B | · |
| Net debt / equity | 0.29× | · |
| Current ratio | 3.82× | 1.28× |
| Revenue CAGR 5y | 13.2% | −7.4% |
| Profit CAGR 5y | · | · |
NEOG bills 14.1× the revenue of TRIB, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | NEOG | TRIB |
|---|---|---|
| FY2024 | $894.7M | $61.6M |
| FY2023 | $924.2M | $56.8M |
| FY2022 | $822.4M | $62.5M |
| FY2021 | $527.2M | $81.1M |
| FY2020 | $468.5M | $102.0M |
| FY2019 | $418.2M | $90.4M |
| FY2018 | $414.2M | $97.0M |
| FY2017 | $397.9M | $99.1M |
| FY2016 | $358.3M | $99.6M |
| FY2015 | $321.3M | $100.2M |
Bottom line
| Fiscal year | NEOG | TRIB |
|---|---|---|
| FY2024 | $-1.1B | $-31.8M |
| FY2023 | $-9.4M | $-24.0M |
| FY2022 | $-22.9M | $-41.0M |
| FY2021 | $48.3M | $875,000 |
| FY2020 | $60.9M | $-6.4M |
| FY2019 | $59.5M | $-28.9M |
| FY2018 | $60.2M | $-22.1M |
| FY2017 | $63.1M | $-40.3M |
| FY2016 | $43.8M | $-100.6M |
| FY2015 | $36.6M | $21.8M |
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | +$833,145,000 | NEOG |
| FY2023 | +$867,368,000 | NEOG |
| FY2022 | +$759,926,000 | NEOG |
| FY2021 | +$446,010,000 | NEOG |
| FY2020 | +$366,479,000 | NEOG |
| FY2019 | +$327,735,000 | NEOG |
| FY2018 | +$317,151,000 | NEOG |
| FY2017 | +$298,790,000 | NEOG |
| FY2016 | +$258,666,000 | NEOG |
| FY2015 | +$221,080,000 | NEOG |
NEOG has reported the higher revenue in every one of these 10 fiscal years. The gap has widened since the earliest year compared.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | −71.3 pp | TRIB |
| FY2023 | +63.9 pp | NEOG |
| FY2022 | +66.9 pp | NEOG |
| FY2021 | +11.4 pp | NEOG |
| FY2020 | +18.9 pp | NEOG |
| FY2019 | +46.3 pp | NEOG |
| FY2018 | +37.9 pp | NEOG |
| FY2017 | +54.9 pp | NEOG |
| FY2016 | +51.0 pp | NEOG |
| FY2015 | −10.8 pp | TRIB |
The higher net margin has changed hands between NEOG and TRIB over this period.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NEOG's net margin has been more volatile than TRIB's over the 10 comparable fiscal years — 40.0 percentage points of standard deviation against 27.4.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between NEOG and TRIB over these 10 fiscal years — NEOG led in 8 and TRIB in 2.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
TRIB's return on equity has been more volatile than NEOG's over the 5 comparable fiscal years — 41.4 percentage points of standard deviation against 1.2.
5 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between NEOG and TRIB over these 5 fiscal years — NEOG led in 4 and TRIB in 1.
5 of 17 comparable fiscal years — a year missing data on either side is not counted.